Liability Arising from Clinical Trials Leigh-Ann Mulcahy FOUR NEW SQUARE LINCOLN’S INN.

Slides:



Advertisements
Similar presentations
Informed consent in research ethics
Advertisements

Biomedical Ethics and Legal Principles
Health & Safety at Work Etc. Act 1974
Legal Aspects of Nursing NUR101 FALL 2008 LECTURE #21 K. Burger, MSEd, MSN, RN,CNE PPP by: Sharon Niggemeier RN MSN Revised kburger8/06.
What happens when research is over – whose obligation? Global Forum for Bioethics in Research VI: What happens when research is over – obligation Banson.
© 2009 The McGraw-Hill Companies, Inc. All rights reserved 3-1 Introduction  Reasons to study medical law and ethics Function at the highest professional.
Research Governance in Practice
RCN Joint Representatives Conference 2013 – Francis Inquiry and RCN Accredited Representatives Chris Cox Director of Legal Services Royal College of Nursing.
ICH GCP, the MHRA and PATHOLOGY PATHOLOGY QUALITY ASSURANCE Rob Wosley MRQA SEPTEMBER 2009.
© Weightmans LLP HAI – LEGAL PERSPECTIVES Infection Prevention Summit Pennine Acute Hospitals NHS Trust Simon Charlton, Associate, Weightmans LLP, Healthcare.
Offences against the person
John Naim, PhD Director Clinical Trials Research Unit
Managing Sponsorship Research Services University of Oxford.
EMACOLEX Budapest 12 and 13 May 2011 QUESTIONNAIRE ON CLINICAL TRIALS Insurance matters.
Legal Aspects of Nursing NUR101 FALL 2009 LECTURE #21 K. Burger, MSEd, MSN, RN,CNE PPP by: Sharon Niggemeier RN MSN Revised kburger8/06.
Professional Accountability Judicial system –Criminal justice system Criminal liability –Civil justice system Civil liability Professional self regulation.
Sheffield April2008 Research ethics committees & the law John Saunders Hon professor, Centre for Philosophy, Humanities & Law, School of Health Science,
Research Ethics & Governance
DO THE CODES APPLY TO MY RESEARCH?
Medical Law Clinical Negligence Hani Azri – LLB Scholar BPP University College Law School London.
Good Clinical Practice GCP
Medico-legal aspects of “off-licence” prescribing in Obstetrics ENTER 2006 CONFERENCE Saj Shah Solicitor/Pharmacist 3 May 2006.
Legal Aspects of Clinical Trials Shekhar Potkar Director Clinical Research Pfizer Limited.
Good Clinical Practice GCP overview
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
ICPHSO: U.S. and Canadian Product Liability and Safety Regulatory Risks Kenneth Ross Bowman and Brooke LLP October 27, 2009.
Legal and Ethical Practices Law- rule of conduct or action prescribed or formally recognized as binding or enforced by a controlling authority Criminal.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Secondary Market Liability Regulatory Prosecution Bob Cooper Emerging Issues in Directors and Officers Liability.
HUMAN RESEARCH HISTORICAL PERSPECTIVE. Objectives Identify the history events that lead to the development of principles, regulations, and guidance.
Criticisms and Reform of Involuntary Manslaughter
“What’s Ethics Got To Do With It” Presentation to the Canberra Evaluation Forum Gary Kent Head Governance Australian Institute of Health and Welfare.
The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?
Copyright © 2004 McGraw-Hill Ryerson Limited 1 PART 2 THE LAW OF TORTS  Chapter 4 – Intentional Interference Prepared by Douglas H. Peterson, University.
OHS Seminar DO THE TIME – avoid the crime! Miles Crawley 8 June 2007.
Copyright © 2008 Pearson Education Canada4-1 Chapter 4: Intentional Torts.
Legal Terminology Biomedical Technology Legal implications in health care  Malpractice: harmful, incorrect, or negligent practice or treatment of a.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
CLINICAL STUDIES AND ETHICS OF SCIENCE Assist.Prof.Dr. Mehmet KARATAS Dept. of History of Medicine & Ethics.
Legal Terminology Biomedical Technology Curriculum/ 2004.
Civil Aviation Authority Slide 1 Risk Taking & Rule Breaking October 2005 THE LEGAL CONSEQUENCES OF BREAKING THE RULES ROBIN ALLAN Deputy Legal Adviser.
The Misapplication or Non- Application of the Precautionary Principle Leigh-Ann Mulcahy FOUR NEW SQUARE LINCOLN’S INN.
Lesson 10: Ethical Issues. Whenever it is possible investigators should inform participants of the objectives of the investigation and get their consent.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Quality Assurance & Quality Control in Pharmaceuticals & Healthcare Industries By- Dr. Sushrut Varun Satpathy MBBS, MD Assistant Professor Department of.
Beyond Regulations: Ethical Considerations in Research
Introduction to Research Governance, Ethics and Integrity Mrs April Lockyer Senior Research Policy Officer (Governance and Integrity)
Ethics in Research A class discussion. What is Ethics in Research? and Why is it Important?
GCP (GOOD CLINICAL PRACTISE)
Research Ethics Dr Nichola Seare Aston Health Research & Innovation Cluster.
Torts. Homework: read section titled: The Idea of Liability and The Idea of torts: Yesterday, Today, and Tomorrow - take notes on reading! Pages
Legal Aspects of Nursing
Unit 3: Assessing Risk in Sport
Health Information Management Technology: An Applied Approach
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Administering Informed Consent Issues for Discussion
Introduction to GCP and Ethical considerations in clinical trials
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Chapter 7Legal Responsibilities for Practice
راهنماي اختصاصي اخلاق در كارآزمايي هاي باليني
Safety at Sea – Where the Law Kicks In
Chapter 13: Ethics and Law
Brussels, June 6, 2007 Paul E. Kalb, M.D., J.D.
Clinical Research Association TURKEY
Biomedical Technology
Ray French Research Governance Manager, ACCORD.
Liability Arising from Clinical Trials
Research, Experimentation, & Clinical Trials
Chapter 11: Law, Ethics, and Professionalism in Health Care
Presentation transcript:

Liability Arising from Clinical Trials Leigh-Ann Mulcahy FOUR NEW SQUARE LINCOLN’S INN

2 Porton Down

3 Research ethics Nuremberg Code 1947 Declaration of Helsinki 1964 – various revisions – current one: 2000 Beecher (USA) & Pappworth (UK) Royal College of Physicians 1967 ABPI Guidelines 1970 Department of Health 1987

4 Regulatory Context Clinical Trials Directive (2001/20/EC) Medicines for Human Use (Clinical Trials) Regulations 2004 EC Commission Guidance Good Clinical Practice Directive (2005/28/EC)/ ICH GCP Guidelines

5 Bodies involved Trial sponsor Investigator Ethics committees Competent authority – in UK, MHRA

6 Sources of civil liability Negligence Product Liability Directive/CPA Contract Human Rights Act 1998, Arts 2, 3, 8 (public authorities only) Rylands v. Fletcher liability? Trespass to the person – assault/battery

7 Criminal liability for injury Common assault/battery Assault contrary to ss. 47, 20 and 18 OAPA 1861 Administering a noxious substance contrary to ss. 23 or 24 OAPA 1861 Any interference with bodily integrity is unlawful unless: (1) In excepted category & justified “for good reason in the public interest” AND (2) Consent

8 Criminal liability for death Unlawful act manslaughter Requires a criminally unlawful act with risk of harm (e.g. assault) Gross negligence manslaughter Civil negligence To criminal degree – jury question

9 Regulatory offences Section 49 Clinical Trials Regulations 2004 – offence to breach certain regulations Section 50 – offence to provide false or misleading information to ethics committee or MHRA Defence of due diligence Penalties – fine/2 years imprisonment

10 Case-law US –Whitlock v. Duke University (1986) –In re Cincinnatti Radiation Litigation (1995) –Grimes v. Kennedy Kreiger Institute Inc (2000) UK –Maddison Inquest (2004) –Pearce v. United Bristol Healthcare NHS Trust (1999) & Chester v. Afshar (2004) - move to US “informed consent” approach?

11 Health Select Committee 2005 Criticisms of: (1) Limited information given to trial participants “….the information patients receive before they enter a trial fails to adequately disclose the risks they might incur….” (2) Exposure of participants to unacceptable risk

12 Conclusions  Importance of informed consent (and ethics compliance?)  Aim to avoid negligence liability regardless of agreement to compensate  Greater risk - non therapeutic research; issues over competence/voluntariness  Note time limits – none for criminal liability; 6 years trespass to person